Roche Pushing Personalized Medicine Concept In China
This article was originally published in PharmAsia News
Executive Summary
Roche's diagnostics business, despite being the world's largest, has long been laying relatively low in China, particularly compared with its large drug business in the country. However, this is now changing as China continues to open up to targeted drugs and companion diagnostics, notably in oncology.